The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Recent research out of Cornell University showed that GLP-1 users' grocery bills have been reduced by as much as 8.6% — with ...

The digital health unicorn sells its chronic condition management and musculoskeletal programs to employers and health plans ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

GLP-1 agonist medications, originally designed to ... GLP-1 agonists mimic the natural hormone glucagon-like peptide-1 (GLP-1), produced in the small intestine, which regulates key functions ...

Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.